Community Academic Profiles

Martin S. Angst

A human in-vivo model for the detection of inflammatory and nociceptive biomarkers

Contact Information

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Martin Angst (650) 498-5109
To view all clinical trials at Stanford, please see the Clinical Trials Directory.

Brief

This study aims to establish a novel approach assisting the rational development of analgesic and anti-inflammatory drugs. In a first step we will test in healthy human volunteers whether proteins mediating inflammation and pain can be detected in an experimentally induced inflammatory skin lesion. Fluids that will be used to detect such proteins will be collected from the inflamed skin site via small porous catheters. We wish to establish the expression pattern of different proteins and correlate it with various tests assessing pain.

Recruiting Status:

Completed

Stanford Recruiting Status:

Completed

Condition(s):

Intervention(s):

  • Procedure: Micro-plasmapheresis

Phase:

N/A

Eligibility

Ages Eligible for Study:

21 years to 60 years

Genders Eligible for Study:

Male and Female

Health of Volunteers:

People with the conditions listed in this trial can not participate as controls.

Key Inclusion Criteria:

1. Age between 21-60.
2. Skin type II or III according to the classification of Fitzpatrick (II: fair skin, always burns, sometimes tans, III: medium skin, sometimes burns, always tans).

Key Exclusion Criteria:

1. History of a significant systemic disease, a dermatological disease, bleeding disorder, or chronic pain.
2. Consumption of analgesic drugs.
3. Hypersensitivity to sunlight.

Additional Study Details

Official Title:

Proof-of-concept study for bio-marker assay validation in humans

Anticipated start date:

Lead Sponsor:

Stanford University

Investigator(s):

Study Type:

Interventional

Purpose:

Diagnostic

Allocation:

Randomized

Masking:

Double Blind

Control:

none

Assignment:

Cross Over

Endpoints:

Unspecified

Primary Outcomes:

  • Cytokine-release profile in response to inflammation, noxious heat, and asministration of a COX-inhibitor

Total Number to be Enrolled:

13

Total Number to be Enrolled at Stanford:

13

More Information

Trial Unique Id: 79723

Locations & Contacts

Stanford Locations & Contacts:

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Martin Angst (650) 498-5109

Non-Stanford Locations:

The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.

This listing was last updated:

11/21/2008

PLEASE NOTE:

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.

Stanford Medicine Resources:

Footer Links: